
    
      This is a double-blind, randomised, parallel group study, where a total of 105 healthy adult
      male volunteers, ≥ 18 and ≤ 55 years of age, non-smoker, will be dosed; 35 subjects per
      treatment group, randomly assigned to one of the 3 treatment arms.
    
  